Evolution and treatment of migraine with oral contraceptives

Cephalalgia

Volumn 20, Issue 3, 2000, Pages 170-174

  Massiou, H ^a   MacGregor, E A ^a,b  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b City of London Migraine Clinic   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DESOGESTREL; ESTRADIOL; ESTROGEN DERIVATIVE; ETHINYLESTRADIOL; GESTAGEN; ORAL CONTRACEPTIVE AGENT;

ARTICLE; DISEASE COURSE; DISEASE SEVERITY; DRUG CONTRAINDICATION; DRUG EFFECT; FEMALE; HEADACHE; HUMAN; MIGRAINE;

AGE FACTORS; CEREBROVASCULAR ACCIDENT; CONTRACEPTIVES, ORAL; FEMALE; HUMANS; ISCHEMIA; MIGRAINE DISORDERS; RISK FACTORS; SMOKING;

EID: 0034454533     PISSN: 03331024     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-2982.2000.00038.x     Document Type: Article

References (55)

1. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain
2. Headache and treatment with oral contraceptives
3. Sex hormones and headache
4. The 150/30 formulation. Experience in the United Kingdom
5. Twelve years of clinical experience with an oral contraceptive containing 30 microg ethinyl-estradiol and 150 microg desogestrel
6. Clinical experience and pharmacological effects of an oral contraceptive containing 20 micrograms oestrogen
7. Sex-hormone-related events in migrainous females. A clinical comparative study between migraine with aura and migraine without aura
8. Migraine and oral contraceptives
9. Migraine without aura and reproductive life events: A clinical epidemiological study in 1300 women
10. The relationship of headache frequency to hormone use in migraine
11. Headache and treatment with oral contraceptives
12. Oral contraceptive drugs and migraine
13. A controlled study of the effect of oral contraceptives on migraine
14. Migraine, a follow-up study of 92 patients
15. Relationship of headache to phase of the menstrual cycle among young women: A daily diary study
16. Migraine without aura and migraine with aura are distinct clinical entities: A study of four hundred and eighty-four male and female migraineurs from the general population
17. Estrogen replacement and migrain aura
18. Migraine attacks and increased platelet aggregability induced by oral contraceptives
19. Platelet aggregation in response to 5HT in migraine patients taking oral contraceptives
20. Can transient ischaemic attacks and classical migraine always be distinguished?
21. TIA's, migraine and platelets
22. Oral 311C90 is effective in treatment of menstrual migraine
23. The efficacy and safety of subcutaneous sumatriptan in the acute treatment of menstrual migraine
24. A double-blind study of dihydroergotamine nasal spray (Diergo®Spray) versus placebo in menstrual migraine
25. Treatment of menstruation-associated migraine headache with subcutaneous sumatriptan
26. Naproxen sodium in menstrual migraine prophylaxis: A double-blind placebo controlled study
27. A pilot study of oral sumatriptan as intermittent prophylaxis of menstruation-related migraine
28. The role of oestradiol withdrawal in the etiology of menstrual migraine
29. Estrogen withdrawal migraine. I Duration of exposure required and attempted prophylaxis by premenstrual estrogen administration
30. Prevention of menstrual migraine by percutaneous estradiol
31. Menstrual migraine: A double blind trial of percutaneous oestradiol
32. Migraine and menstruation: A pilot study
33. Efficacy and safety of percutaneous estradiol versus placebo in menstrual migraine
34. Perimenstrual migraine: Effect of estraderm TTS and the value of contingent negative variation and exterotemporalis muscle suppression test
35. Correlation between oestradiol plasma level and therapeutic effect on menstrual migraine
36. Migraine and subsequent risk of stroke in the physicians' health study
37. History of migraine and risk of cerebral ischemia in young adults
38. Oral contraceptives and stroke in young women. Associated risk factors
39. Case-control study of oral contraceptives and risk of thromboembolic stroke: Results from international study on oral contraceptives and health of young women
40. A controlled study of ischaemic stroke risk in migraine patients
41. Oral contraception and risk of a cerebral thromboembolic attack: Result of a case-control study
42. Oral contraceptives, pregnancy and the risk of cerebral thromboembolism: The influence of diabetes, hyptertension, migraine and previous thrombotic disease
43. Association between migraine and stroke in a large-scale epidemiological study of the United States
44. Stroke in users of low-dose oral contraceptives
45. Migraine as a risk of ischemic stroke: A case-control study
46. Case-control study of migraine and risk of ischemic stroke in young women
47. Ischaemic stroke and comblued oral contraceptives: Results of an international, multicentre, case-control study
48. Migraine and stroke in young women: Case-control study
49. Migraine and oral contraception
50. The clinical characteristics of headache during impending infarction in women taking oral contraceptives
51. Migraine and oral contraceptives
52. Recommendations for clinical practice. Combined oral contraceptives, migraine and ischaemic stroke
53. The place of combined oral contraceptives in contraception